Shu Y, Zhang W, Hou Q, Zhao L, Zhang S, Zhou J, et al. Prognostic significance of frequent CLDN18-ARHGAP26/6 fusion in gastric signet-ring cell cancer. Nat Commun. 2018;9:2447.

Article  PubMed  PubMed Central  Google Scholar 

Benesch MGK, Mathieson A. Epidemiology of signet ring cell adenocarcinomas. Cancers (Basel). 2020;12:1544.

Article  PubMed  Google Scholar 

Cancer Genome Atlas N. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012;487:330–7.

Article  Google Scholar 

Korphaisarn K, Morris V, Davis JS, Overman MJ, Fogelman DR, Kee BK, et al. Signet ring cell colorectal cancer: genomic insights into a rare subpopulation of colorectal adenocarcinoma. Br J Cancer. 2019;121:505–10.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nam JY, Oh BY, Hong HK, Bae JS, Kim TW, Ha SY, et al. Molecular characterization of colorectal signet-ring cell carcinoma using whole-exome and RNA sequencing. Transl Oncol. 2018;11:836–44.

Article  PubMed  PubMed Central  Google Scholar 

Li Y, Li J, Wang R, Zhang L, Fu G, Wang X, et al. Frequent RNF43 mutation contributes to moderate activation of Wnt signaling in colorectal signet-ring cell carcinoma. Protein Cell. 2020;11:292–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Alvi MA, Loughrey MB, Dunne P, McQuaid S, Turkington R, Fuchs MA, et al. Molecular profiling of signet ring cell colorectal cancer provides a strong rationale for genomic targeted and immune checkpoint inhibitor therapies. Br J Cancer. 2017;117:203–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Huang S, Wang Z, Zhou J, Huang J, Zhou L, Luo J, et al. EZH2 inhibitor GSK126 suppresses antitumor immunity by driving production of myeloid-derived suppressor cells. Cancer Res. 2019;79:2009–20.

Article  CAS  PubMed  Google Scholar 

Revia S, Seretny A, Wendler L, Banito A, Eckert C, Breuer K, et al. Histone H3K27 demethylase KDM6A is an epigenetic gatekeeper of mTORC1 signalling in cancer. Gut. 2022;71:1613–28.

CAS  PubMed  Google Scholar 

Kong N, Zhang R, Wu G, Sui X, Wang J, Kim NY, et al. Intravesical delivery of KDM6A-mRNA via mucoadhesive nanoparticles inhibits the metastasis of bladder cancer. Proc Natl Acad Sci USA 2022;119:e2112696119.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kalisz M, Bernardo E, Beucher A, Maestro MA, Del Pozo N, Millán I, et al. HNF1A recruits KDM6A to activate differentiated acinar cell programs that suppress pancreatic cancer. EMBO J. 2020;39:e102808.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Stief SM, Hanneforth AL, Weser S, Mattes R, Carlet M, Liu WH, et al. Loss of KDM6A confers drug resistance in acute myeloid leukemia. Leukemia. 2020;34:50–62.

Article  PubMed  Google Scholar 

Bosselut R. Pleiotropic functions of H3K27Me3 demethylases in immune cell differentiation. Trends Immunol. 2016;37:102–13.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Manna S, Kim JK, Bauge C, Cam M, Zhao Y, Shetty J, et al. Histone H3 Lysine 27 demethylases Jmjd3 and Utx are required for T-cell differentiation. Nat Commun. 2015;6:8152.

Article  PubMed  Google Scholar 

Northrup D, Yagi R, Cui K, Proctor WR, Wang C, Placek K, et al. Histone demethylases UTX and JMJD3 are required for NKT cell development in mice. Cell Biosci. 2017;7:25.

Article  PubMed  PubMed Central  Google Scholar 

Cook KD, Shpargel KB, Starmer J, Whitfield-Larry F, Conley B, Allard DE, et al. T follicular helper cell-dependent clearance of a persistent virus infection requires T cell expression of the histone demethylase UTX. Immunity. 2015;43:703–14.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Itoh Y, Golden LC, Itoh N, Matsukawa MA, Ren E, Tse V, et al. The X-linked histone demethylase Kdm6a in CD4+ T lymphocytes modulates autoimmunity. J Clin Investig. 2019;129:3852–63.

Article  PubMed  PubMed Central  Google Scholar 

Gao J, Gu J, Pan X, Gan X, Ju Z, Zhang S, et al. Blockade of miR-142-3p promotes anti-apoptotic and suppressive function by inducing KDM6A-mediated H3K27me3 demethylation in induced regulatory T cells. Cell Death Dis. 2019;10:332.

Article  PubMed  PubMed Central  Google Scholar 

Li X, Zhang Q, Shi Q, Liu Y, Zhao K, Shen Q, et al. Demethylase Kdm6a epigenetically promotes IL-6 and IFN-beta production in macrophages. J Autoimmun. 2017;80:85–94.

Article  CAS  PubMed  Google Scholar 

Chen J, Xu X, Li Y, Li F, Zhang J, Xu Q, et al. Kdm6a suppresses the alternative activation of macrophages and impairs energy expenditure in obesity. Cell Death Differ. 2021;28:1688–704.

Article  CAS  PubMed  Google Scholar 

Kobatake K, Ikeda KI, Nakata Y, Yamasaki N, Ueda T, Kanai A, et al. Kdm6a deficiency activates inflammatory pathways, promotes M2 macrophage polarization, and causes bladder cancer in cooperation with p53 dysfunction. Clin Cancer Res. 2020;26:2065–79.

Article  CAS  PubMed  Google Scholar 

Kim KH, Roberts CW. Targeting EZH2 in cancer. Nat Med. 2016;22:128–34.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Schulz WA, Lang A, Koch J, Greife A. The histone demethylase UTX/KDM6A in cancer: progress and puzzles. Int J Cancer. 2019;145:614–20.

Article  CAS  PubMed  Google Scholar 

Rodriguez-Vida A, Lerner SP, Bellmunt J. The cancer genome atlas project in bladder cancer. Cancer Treat Res. 2018;175:259–71.

Article  PubMed  Google Scholar 

Wilcox AN, Silverman DT, Friesen MC, Locke SJ, Russ DE, Hyun N, et al. Smoking status, usual adult occupation, and risk of recurrent urothelial bladder carcinoma: data from The Cancer Genome Atlas (TCGA) Project. Cancer Causes Control. 2016;27:1429–35.

Article  PubMed  PubMed Central  Google Scholar 

Wang L, Shilatifard A. UTX mutations in human cancer. Cancer Cell. 2019;35:168–76.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Revia S, Seretny A, Wendler L, Banito A, Eckert C, Breuer K, et al. Histone H3K27 demethylase KDM6A is an epigenetic gatekeeper of mTORC1 signalling in cancer. Gut. 2022;71:1613–1628.

CAS  PubMed  Google Scholar 

Lee MG, Villa R, Trojer P, Norman J, Yan KP, Reinberg D, et al. Demethylation of H3K27 regulates polycomb recruitment and H2A ubiquitination. Science. 2007;318:447–50.

Article  CAS  PubMed  Google Scholar 

Ler LD, Ghosh S, Chai X, Thike AA, Heng HL, Siew EY, et al. Loss of tumor suppressor KDM6A amplifies PRC2-regulated transcriptional repression in bladder cancer and can be targeted through inhibition of EZH2. Sci Transl Med. 2017;9:eaai8312.

Article  PubMed  Google Scholar 

Liu Y, Qiu N, Shen L, Liu Q, Zhang J, Cheng YY, et al. Nanocarrier-mediated immunogenic chemotherapy for triple negative breast cancer. J Control Release. 2020;323:431–41.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bhattacharya S, Ghosh A, Maiti S, Ahir M, Debnath GH, Gupta P, et al. Delivery of thymoquinone through hyaluronic acid-decorated mixed Pluronic® nanoparticles to attenuate angiogenesis and metastasis of triple-negative breast cancer. J Control Release. 2020;322:357–74.

Article  CAS  PubMed  Google Scholar 

Ceccaldi R, Sarangi P, D’Andrea AD. The Fanconi anaemia pathway: new players and new functions. Nat Rev Mol Cell Biol. 2016;17:337–49.

Article  CAS  PubMed  Google Scholar 

Cribbs AP, Terlecki-Zaniewicz S, Philpott M, Baardman J, Ahern D, Lindow M, et al. Histone H3K27me3 demethylases regulate human Th17 cell development and effector functions by impacting on metabolism. Proc Natl Acad Sci USA. 2020;117:6056–66.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Curiel TJ, Coukos G, Zou L, Alvarez X, Cheng P, Mottram P, et al. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med. 2004;10:942–9.

Article  CAS  PubMed  Google Scholar 

Shin HM, Kapoor VN, Kim G, Li P, Kim HR, Suresh M, et al. Transient expression of ZBTB32 in anti-viral CD8+ T cells limits the magnitude of the effector response and the generation of memory. PLoS Pathog. 2017;13:e1006544.

Article  PubMed  PubMed Central  Google Scholar 

Li Y, Zhai P, Zheng Y, Zhang J, Kellum JA, Peng Z. Csf2 attenuated sepsis-induced acute kidney injury by promoting alternative macrophage transition. Front Immunol. 2020;11:1415.

Article  CAS  PubMed